 ENGLEWOOD, Colo., Aug. 12, 2021 PRNewswire -- Ampio Pharmaceuticals, Inc. NYSE American: AMPE, a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, reminds stockholders to vote on the proposals listed in the Companys proxy statement in advance of its upcoming annual meeting. 